Clinical trial
TART - Troglitazone Atherosclerosis Regression Trial
NCT00116545 is registered in ClinicalTrials.gov with Parke-Davis as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- TART - Troglitazone Atherosclerosis Regression Trial
- Lead sponsor
- Parke-Davis
- Phase
- Phase 2/3
- Overall status
- Completed
- Start date
- January 31, 1997
- Completion date
- April 30, 2000
- Enrollment
- 288
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.